Published in Am Heart J on September 01, 1993
Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation (2009) 3.55
Prognostic value of 6-minute walk test in stable outpatients with heart failure. Tex Heart Inst J (2007) 1.23
Race, gender, and mortality in adults > or =65 years of age with incident heart failure (from the Cardiovascular Health Study). Am J Cardiol (2009) 0.90
Sex-related differences in patients' responses to heart failure therapy. Nat Rev Cardiol (2012) 0.83
Heart failure in acute ischemic stroke. Curr Cardiol Rev (2010) 0.77
Epidemiological burden of heart failure. Heart (1998) 0.75
Cardiogenic diabetes. Heart Fail Rev (2014) 0.75
Hypertension, hypertrophy, heart failure. Heart (1996) 0.75
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J (1975) 2.71
Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J (1980) 1.85
Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol (1991) 1.66
Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation (1994) 1.63
Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet (1979) 1.55
Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res (1993) 1.53
Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1993) 1.51
Myocardial turnover of endogenous opioids and calcitonin-gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing-induced angina pectoris. Cardiology (1998) 1.51
Early changes in longitudinal performance predict future improvement in global left ventricular function during long term beta adrenergic blockade. Heart (2000) 1.49
Heart rate dependency of cardiac performance in heart failure patients treated with metoprolol. Eur Heart J (1999) 1.48
Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. BMJ (1993) 1.44
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes. Int J Cardiol (1999) 1.40
Hypertonic saline without or with dextran-70 in the treatment of experimental acute myocardial ischemia and reperfusion. Crit Care Med (1999) 1.37
The effects of transcutaneous electrical nerve stimulation in patients with severe angina pectoris. Circulation (1985) 1.34
Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol. Br Heart J (1974) 1.20
In vivo MR imaging of magnetically labeled human embryonic stem cells. Life Sci (2006) 1.15
Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy. Circulation (1996) 1.14
Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes (1999) 1.11
Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy. Br Heart J (1980) 1.10
Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents. Br Heart J (1979) 1.07
A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med (1983) 1.06
The role of beta-blockers in left ventricular dysfunction and heart failure. Drugs (1997) 1.04
Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol (1994) 0.99
Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial. Am Heart J (2001) 0.99
Effects of thoracic epidural anesthesia on coronary arteries and arterioles in patients with coronary artery disease. Anesthesiology (1990) 0.99
Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure. Heart (2003) 0.98
The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation (1983) 0.98
Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with idiopathic dilated cardiomyopathy. Autoimmunity (2000) 0.97
Catecholamine metabolism during pacing-induced angina pectoris and the effect of transcutaneous electrical nerve stimulation. Am Heart J (1987) 0.96
An echocardiographic evaluation of patients with idiopathic heart failure. Chest (1995) 0.93
Bioenergetic, functional and morphological consequences of postinfarct cardiac remodeling in the rat. J Mol Cell Cardiol (1999) 0.93
Treatment of pain in acute myocardial infarction. Br Heart J (1989) 0.93
Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathy. J Med Virol (1993) 0.92
Beta-blocking agents in heart failure. Should they be used and how? Eur Heart J (1996) 0.90
Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene. Endocrinology (2000) 0.90
A new insight into adriamycin-induced cardiotoxicity. Int J Cardiol (1990) 0.89
Influence of naloxone on the effects of high frequency transcutaneous electrical nerve stimulation in angina pectoris induced by atrial pacing. Br Heart J (1989) 0.88
Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction. Am J Cardiol (1983) 0.88
Hemodynamic effects of the cardioselective beta-blocking agent metoprolol in acute myocardial infarction. A 24-hour catheterization study. Acta Med Scand (1978) 0.87
Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction. Acta Med Scand Suppl (1976) 0.87
Nitric oxide synthesis and metabolism in man. Ann N Y Acad Sci (1994) 0.86
Clinical results with prenalterol in patients with heart failure. Am Heart J (1981) 0.85
Effects of pacing-induced myocardial stress and spinal cord stimulation on whole body and cardiac norepinephrine spillover. Eur Heart J (1997) 0.85
Cardiac nuclear hormone receptor mRNA in heart failure in man. Life Sci (1996) 0.85
Acute haemodynamic effects of felodipine in congestive heart failure. Eur J Clin Pharmacol (1985) 0.85
Idiopathic dilated cardiomyopathy among Swedish patients with congestive heart failure. Eur Heart J (1995) 0.85
Effect of metoprolol on activity of beta-adrenoceptor coupled to guanine nucleotide binding regulatory proteins in adriamycin-induced cardiotoxicity. Basic Res Cardiol (1991) 0.84
Growth hormone alone or combined with metoprolol preserves cardiac function after myocardial infarction in rats. Eur J Heart Fail (2001) 0.84
The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure. A study on diastolic function, heart rate and myocardial metabolism following intravenous metoprolol. Eur Heart J (1993) 0.84
Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study. J Am Coll Cardiol (2001) 0.83
Beta-blockers in dilated cardiomyopathies: they work. Eur Heart J (1983) 0.83
Effects of felodipine on systemic and coronary haemodynamics in patients with angina pectoris. Eur Heart J (1984) 0.82
The use of dobutamine in myocardial infarction for reversal of the cardiodepressive effect of metoprolol. Br J Clin Pharmacol (1978) 0.82
Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant (1994) 0.82
Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Göteborg Metoprolol Trial). Am J Cardiol (1997) 0.82
Predictors and evolution of renal function during 9 years following heart transplantation. J Am Soc Nephrol (2000) 0.82
Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure. Eur J Heart Fail (2003) 0.81
Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial. Cardiovasc Drugs Ther (1996) 0.81
Effects of iohexol and metrizoate on myocardial blood flow and metabolism. Acta Radiol Suppl (1983) 0.81
Increase in functional activity rather than in amount of Gi-alpha in failing human heart with dilated cardiomyopathy. Cardiovasc Res (1992) 0.80
Effects of complete heart block on myocardial function, morphology, and energy metabolism in the rat. Europace (2007) 0.80
Selective beta(1)-blockade improves cardiac bioenergetics and function and decreases neuroendocrine activation in rats during early postinfarct remodeling. Biochem Biophys Res Commun (2001) 0.80
Göteborg Metoprolol Trial: clinical observations. Am J Cardiol (1984) 0.80
Effect of cardioselective beta-blockade on heart function and chest pain in acute myocardial infarction. Acta Med Scand Suppl (1976) 0.79
Effects of nifedipine on arterial concentration and myocardial extraction of catecholamines during pacing-induced angina pectoris. J Cardiovasc Pharmacol (1984) 0.79
Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients. Clin Pharmacol Ther (2012) 0.79
Growth hormone improves bioenergetics and decreases catecholamines in postinfarct rat hearts. Endocrinology (2000) 0.79
Correlation between enzymatic estimation of infarct size and early mortality rate. Br Heart J (1983) 0.79
Heart rate variability measurement correlates with cardiac norepinephrine spillover in congestive heart failure. Am J Cardiol (2001) 0.79
Effect of metoprolol on chest pain in acute myocardial infarction. Br Heart J (1984) 0.78
Possible adrenergic effects on heart protein metabolism. Acta Med Scand Suppl (1983) 0.78
Relationship between infarct size and incidence of severe ventricular arrhythmias in a double-blind trial with metoprolol in acute myocardial infarction. Int J Cardiol (1984) 0.78
High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate. Eur Heart J (1999) 0.78
Proceedings: Chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J (1976) 0.78
Enzymatically and electrocardiographically estimated infarct size in relation to pain in acute myocardial infarction. Cardiology (1984) 0.77
Proceedings: Effects of cardioselective beta-blockers on chest pain, ECG, and heart function in acute myocardial infarction. Br Heart J (1976) 0.77
The role of beta-blockers in the treatment of cardiomyopathy and ischaemic heart failure. Drugs (1994) 0.77
Comparison of atrial pacing and the cold pressor test in patients with angina pectoris. Clin Sci (Lond) (1984) 0.77
Göteborg Metoprolol Trial: effects on chest pain. Am J Cardiol (1984) 0.76
Ventricular adenine nucleotide translocator mRNA is upregulated in dilated cardiomyopathy. Cardiovasc Res (1993) 0.76
In vivo metabolic imaging of cardiac bioenergetics in transgenic mice. Biochem Biophys Res Commun (2000) 0.76
Effect of beta-adrenoceptor stimulation on the human bladder in vivo. Urol Int (1978) 0.76
Variability, prediction and prognostic significance of chest pain in acute myocardial infarction. Cardiology (1986) 0.76
Effects on mortality during five years after early intervention with metoprolol in suspected acute myocardial infarction. Acta Med Scand (1988) 0.76
Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure. Br Heart J (1994) 0.76
Intravaginal electrical stimulation. Clinical experiments on bladder inhibition. Scand J Urol Nephrol Suppl (1977) 0.76
Na,K-ATPase receptor subunits alpha 1, alpha 2 and alpha 3 mRNA in dilated cardiomyopathy. Biol Pharm Bull (1995) 0.76
Göteborg Metoprolol Trial: mortality and causes of death. Am J Cardiol (1984) 0.76
Graft coronary artery disease is strongly related to the aetiology of heart failure and cellular rejections. Eur Heart J (1999) 0.76
beta-Adrenoceptor stimulation of the human urinary bladder in vivo. Acta Pharmacol Toxicol (Copenh) (1978) 0.75
MIC trial: metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing. Eur J Heart Fail (2000) 0.75
Development of congestive heart failure after treatment with metoprolol in acute myocardial infarction. Br Heart J (1984) 0.75
Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure. Acta Med Scand Suppl (1982) 0.75
Göteborg Metoprolol Trial: electrocardiographically estimated infarct size. Am J Cardiol (1984) 0.75
Effects of prenalterol administered orally in patients with congestive heart failure. Acta Med Scand Suppl (1982) 0.75
The time course in acute myocardial infarction evaluated with precordial mapping and standard ECG. Clin Cardiol (1983) 0.75